Companies: 10,795·Total market cap: $144.5T
AbbVie Inc.

AbbVie Inc.

ABBVNYSEHealthcare● Active
$227.23
+$2.29(+1.02%)
Market Cap$401.5B
P/E Ratio—
52W High$244.81
52W Low$181.73
Overview

AbbVie Inc. (ABBV) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ABBV · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$5.26B▼ -5.4% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$5.23B
cashAndCashEquivalents
Short-Term Investments
$28.0M
shortTermInvestments
YoY Change vs Prior Year
-5.4%
vs prior fiscal year
Latest Quarter
$9.39B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$5.26BCash on Hand
Total Debt$69.07BTotal Debt
Net Cash / Net Debt−$63.81BNet Debt Position
Cash vs Debt Ratio
Cash 7%Debt 93%

AbbVie Inc. carries a net debt position of $63.81B. Total debt ($69.07B) exceeds cash on hand ($5.26B). AbbVie Inc. cash vs debt ratio: 7% cash / 93% debt.

Net Cash = Cash & ST Investments − Total Debt$5.26B − $69.07B = −$63.81B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ABBV annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$5.26B-5.4%
Dec 31, 2024$5.55B-56.7%
Dec 31, 2023$12.82B+38.9%
Dec 31, 2022$9.23B-6.1%
Dec 31, 2021$9.83B+15.9%
ABBV cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Merck & Co., Inc.
Merck & Co., Inc.
MRK
$14.56B4.9%#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#5
AbbVie Inc.
AbbVie Inc.YOU
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

AbbVie Inc. (ABBV) cash on hand as of December 31, 2025 is $5.26B, comprising $5.23B in cash and cash equivalents (CCE) plus $28.0M in short-term investments — reported as AbbVie Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as AbbVie Inc. cash reserves or cash position.

AbbVie Inc. annual cash on hand history shows decreased -5.4% in 2025: decreased -5.4% in 2025. AbbVie Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

AbbVie Inc. carries total debt of $69.07B against cash of $5.26B, resulting in a net debt position of -$63.81B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ABBV cash on hand · 5 questions

As of December 31, 2025, AbbVie Inc. (ABBV) has $5.26B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $5.23B in cash and cash equivalents (CCE) plus $28,000,000 in short-term investments. Latest quarter (March 31, 2026): $9.39B. Data sourced from the annual 10-K filing via FMP.

ABBV cash on handABBV cash reservesABBV cash 2025how much cash does ABBV have

▸ Source: FMP /balance-sheet-statement · US GAAP · AbbVie Inc. · AbbVie Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025